// App-Quantinova.ai

207 : Circulating tumor cells (CTC) in metastatic hepatocellular carcinoma (HCC): Comparison to control patients with nonmalignant liver diseases (NMLD) and exploratory characterization by next generation sequencing (NGS).

Researchers

Presenter

  • Robin Katie Kelley

Principal Investigators

  • Mark Jesus Mendoza Magbanua

  • Timothy M Butler

  • Alan Paul Venook

  • Eric Andrew Collisson

  • Nikoletta Sidiropoulos

  • Jimmy Hwang

  • Kimberley Evason

  • Bilal Hameed

  • Elizabeth M Wayne

  • Francis Y Yao

  • Iche Siah

  • John W. Park

Medical Centers

  • Oregon Health and Science University, Portland, OR

  • University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA

  • University of California, San Francisco, San Francisco, CA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Liver cancer

  • Solid malignancies

Biomarkers

  • Peripheral blood mononuclear cell

  • Circulating tumor cells

  • Epithelial Cell Adhesion Molecule

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final